Levalbuterol HCL Solution

Award Notice Posted

Solicitation number
SPE2D221R0116
Agency
Awarded
to Teva Pharmaceuticals Usa, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D222D0146 Federal IDV award
Place of performance
Cheshire England United Kingdom

Notice details come from SAM.gov. Updated .

Notice text

3 versions

Update #3 · Latest ·

P00003 SPE2D222D0146 Modification to incorporate Drug Supply Chain Security Act language into solication for subject contract. 

P00002 SPE2D222D0146 Modification to Invoke Option Year 1. 

P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) 

Contract Award for Leavalbuterol HCL Solution SPE2D222D0146

Awarded contract SPE2D222D0146 to Teva Pharmaceuticals USA, Inc. for 5687207.30 on 2022-08-31.

Update #2 ·

P00002 SPE2D222D0146 Modification to Invoke Option Year 1. 

P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) 

Contract Award for Leavalbuterol HCL Solution SPE2D222D0146

Awarded contract SPE2D222D0146 to Teva Pharmaceuticals USA, Inc. for 5687207.30 on 2022-08-31.

Update #1 ·

Contract Award for Leavalbuterol HCL Solution SPE2D222D0146

Awarded contract SPE2D222D0146 to Teva Pharmaceuticals USA, Inc. for 5687207.30 on 2022-08-31.

Files

Notice history

Notice Type Posted
This notice Award Award Notice
Levalbuterol HCL Solution Latest solicitation Solicitation
Levalbuterol HCL Solution Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors